Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 224

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 224
---
 reserve the right to discontinue the program at any time. We intend to utilize this authorization over a multi-year period, subject to market and industry conditions. Repurchases may be made from time to time at prevailing market prices, subject to certain restrictions on volume, pricing and timing. The repurchases are affected from time to time in the open market, through negotiated transactions, including accelerated share repurchase agreements, and through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Our stock repurchase program is discretionary, as we are under no obligation to repurchase shares. We repurchase shares under the program when we believe it is a prudent use of capital. The excess cost of the repurchased shares over par value is charged on a pro rata basis to additional paid-in capital and retained earnings.A summary of common stock repurchases for the years ended December 31, 2024 and 2023 is as follows:Years Ended December 31 20242023Shares repurchased6.7 5.8 Average price per share$435.32 $463.53 Aggregate cost$2,900 $2,676 Authorization remaining at end of year$9,300 $4,200 We expect to utilize the remaining authorized amount over a multi-year period, subject to market and industry conditions.For additional information regarding the use of capital for debt security repurchases, see Note 13, “Debt.”

 -126-

Elevance Health, Inc.Notes to Consolidated Financial Statements (continued)

16. Accumulated Other Comprehensive (Loss) Income

A reconciliation of the components of accumulated other comprehensive (loss) income at December 31, 2024, 2023, and 2022 is as follows:202420232022Net unrealized investment gains:Beginning of year balance$(632)$(1,755)$494 Other comprehensive (loss) income before reclassifications, net of tax benefit (expense)  of $44, $(218), and $926, respectively(153)760 (2,614)Amounts reclassified from accumulated other comprehensive income, net of tax expense of $(82), $(113), and $(94), respectively256 357 354 Other comprehensive income (loss)103 1,117 (2,260)Other comprehensive income attributable to noncontrolling interests, net of tax benefit (expense) of $1, $1, and $(3), respectively6 6